The effects of tranexamic acid and 6% hydroxyethyl starch (HES) solution (130/0.4) on postoperative bleeding in coronary artery bypass graft (CABG) surgery

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 5959-5971

  Yanartas, M ^a   Baysal, A ^a   Aydin C ^b   Ay, Y ^b   Kara, I ^c   Aydin E ^a   Cevirme, D ^a   Koksal C ^a   Sunar, H ^a  

^a Training and Research Hospital   (Turkey)

^b Department of Pediatric Cardiology   (Turkey)

^c Cardiovascular Surgery Clinic   (Turkey)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Colloid; Crystalloid; Hemostasis; Hetastarch; Renal; Tranexamic acid

Indexed keywords

HEMOGLOBIN; HETASTARCH; RINGER LACTATE SOLUTION; TRANEXAMIC ACID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING PARAMETERS; BLOOD TRANSFUSION; CHEST TUBE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMATOCRIT; HUMAN; INTUBATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OPERATIVE BLOOD LOSS; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STERNOTOMY; SURGICAL DRAINAGE; SURGICAL RISK; THROMBOCYTE;

EID: 84931275119     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and metaanalysis. Anesth Analg 2012; 114: 159-169.
2. Shi XY, Zou Z, He XY, Xu HT, Yuan HB, Liu H. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials. Eur J Clin Pharmacol 2011; 8: 767-782.
3. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in vardiopulmonary bypass prime solutions (A randomized controlled trial). J Cardiothorac Surg 2008; 3: 45.
4. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003; 99: 42-7.
5. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010; 104: 691-7.
6. Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101: 629-34.
7. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007; 35: 2740-6.
8. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009; 108: 30-6.
9. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999; 88: 992-8.
10. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88: 999-1003.
11. Koster A, Börgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013; 110: 34-40.
12. Ngaage DL, Bland JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010; 37: 1375-83.
13. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. Eur J Heart Fail 2008; 10: 188-95.
14. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann 2009; 17: 368-72.
15. Gurbuz HA, Durukan AB, Salman N, Tavlasoglu M, Durukan E, Ucar HI, Yorgancioglu C. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg 2013; 8: 71-6.
16. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol 2010; 8: 584-591.
17. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47: 1207-15.
18. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesth. Belg 2003; 54: 207-215.
19. Kimenai D, Bastianen G, Daane C, Megens-Bastiaanse C, van der Meer N, Scohy T, Gerritse B. Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: a randomized controlled trial. Perfusion 2013; 28: 512-519.
20. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenperä MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004; 98: 291-7.
21. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Br J Anaesth 2010; 104: 691-7.
22. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94: 427-33.
23. Maha AA, Mohamed S. Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion 2004; 19: 41-45.
24. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. HES and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Intern 2003; 64: 1046-49.
25. Knotzer H, Pajk W, Maier S, Dünser MW, Ulmer H, Schwarz B, Salak N, Hasibeder WR. Comparison of lactated Ringer’s, gelatine and blood resuscitation on intestinal oxygen supply and mucosal tissue oxygen tension in haemorrhagic shock. Br J Anaesth 2006; 97: 509-16.
26. Base EM, Standl T, Lassnigg A, Skhirtladze K, Jungheinrich C, Gayko D, Hiesmayr M. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25: 407-14.
27. Damar E, Aksun M, Girgin S, Goktogan T, Yilmaz E, Aran G, Sencan A, Gurbuz A, Karahan N. A comparison of the hemodynamic, metabolic, renal and hemostatic effects of the use of Ringer solution and adjuvant 6% hydroxyethyl starch 130/0.4 as a pump prime solution in coronary artery bypass grafting. Turkish Journal of Thoracic and Cardiovascular Surgery 2012; 20: 22-31.